Ozempic Alternatives & Comparison
How Ozempic (semaglutide) compares to Mounjaro, Trulicity, Rybelsus — mechanism, trial weight-loss results, and cost — plus where to compare vetted providers.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Ozempic Alternatives Compared
Dual GIP/GLP-1 mechanism, often greater A1c and weight reduction
Mounjaro's tirzepatide activates both GIP and GLP-1 receptors — making it a "dual agonist" or "twincretin." For diabetes, this dual action powerfully lowers blood sugar by increasing insulin secretion and reducing glucagon.
Mounjaro (tirzepatide) wins on weight loss and A1C: SURPASS-2 head-to-head at 40 weeks showed Mounjaro 15mg -11.2 kg vs Ozempic 1mg -5.7 kg, and a 2.30% A1C drop vs 1.86%. Ozempic wins on cardiovascular outcomes — SUSTAIN-6 demonstrated a 26% reduction in MACE in T2D patients; Mounjaro's SURPASS-CVOT reads out in 2027. Both are FDA-approved for type 2 diabetes only; chronic weight management requires Wegovy or Zepbound. Choose based on glycemic-magnitude vs proven CV protection.
Full Mounjaro vs Ozempic comparison →Once-weekly GLP-1 alternative with a long real-world track record
Dulaglutide is a long-acting GLP-1 receptor agonist engineered by fusing two modified GLP-1 peptide chains to a human IgG4 Fc fragment, which extends the half-life to about five days and allows once-weekly dosing.
Ozempic (semaglutide) is the stronger T2D molecule head-to-head: SUSTAIN-7 at 40 weeks showed Ozempic 1 mg dropped A1C 1.8% and weight 6.5 kg, vs Trulicity 1.5 mg's 1.4% A1C and 3.0 kg. Both have FDA-approved cardiovascular indications, but the trials differ — SUSTAIN-6 showed Ozempic cut MACE 26% in a secondary-prevention cohort, while REWIND showed Trulicity cut MACE 12% across a larger primary-prevention population. Trulicity wins on pediatric labeling (ages 10+) and advanced kidney disease (AWARD-7). Both are weekly injections, T2D-only labels.
Full Trulicity vs Ozempic comparison →Oral daily formulation of the same molecule for patients who prefer to avoid injections
Rybelsus delivers semaglutide — a GLP-1 receptor agonist — in tablet form by co-formulating each pill with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), an absorption enhancer that transiently raises gastric pH and helps the semaglutide peptide cross the gastric mucosa intact before stomach acid and proteases can degrade it.
Ozempic and Rybelsus are the same molecule (semaglutide) in different formulations. Ozempic — a once-weekly subcutaneous injection at 0.25-2 mg — typically delivers larger A1C reductions (~1.4-1.8%) than Rybelsus 14 mg daily (~1.0-1.4%), because oral semaglutide has only ~1% bioavailability versus ~89% subcutaneous. Both have proven cardiovascular benefit (SUSTAIN-6 for Ozempic, PIONEER 6 for Rybelsus). Pick Rybelsus only if you are genuinely needle-averse.
Full Rybelsus vs Ozempic comparison →Same molecule, higher maintenance dose, FDA-approved specifically for weight management
Wegovy delivers semaglutide 2.4mg — the highest approved dose — via once-weekly self-injection. It mimics the GLP-1 hormone to signal fullness to the brain, slow stomach emptying, and reduce overall caloric intake.
Wegovy and Ozempic are pharmacologically identical — both are once-weekly subcutaneous semaglutide manufactured by Novo Nordisk. The split is regulatory: Wegovy carries the FDA labels for chronic weight management (STEP-1) and cardiovascular risk reduction in obesity (SELECT), with a 2.4 mg max dose. Ozempic carries the type 2 diabetes label and CV risk reduction in T2D (SUSTAIN-6), capped at 2 mg. The right brand depends on the indication your insurance will cover.
Full Wegovy vs Ozempic comparison →Compare compounded Semaglutide providers
Compounded semaglutide runs a median of $199/month across 251 vetted-provider price points (range $65–$599). Featured partners below, ranked by our partner-economics ordering.
Compare compounded Tirzepatide providers
Compounded tirzepatide runs a median of $275/month across 219 vetted-provider price points (range $99–$1,100). Featured partners below, ranked by our partner-economics ordering.
Compare every Ozempic provider
See current pricing, verification status, form, and states served across every vetted provider in one place.